Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

H. Hidaka · SciRah

Researcher profile · Semantic Scholar

H. Hidaka

Share profile

H. Hidaka — researcher profile on SciRah

h-index: 31
Works: 141
Citations: 3,346

Most-cited papers

Evidence-based clinical practice guidelines for Liver Cirrhosis 2020
H. Yoshiji, S. Nagoshi, Takemi Akahane, Yoshinari Asaoka +17 more
2021Journal of gastroenterology387 citations Open access
Semantic Scholar
Orantinib versus placebo combined with transcatheter arterial chemoembolisation in patients with unresectable hepatocellular carcinoma (ORIENTAL): a randomised, double-blind, placebo-controlled, multicentre, phase 3 study.
M. Kudo, A. Cheng, Joong-Won Park, J. Park +10 more
2018The Lancet Gastroenterology and Hepatology170 citations
Semantic Scholar
Evidence‐based clinical practice guidelines for liver cirrhosis 2020
H. Yoshiji, S. Nagoshi, Takemi Akahane, Yoshinari Asaoka +17 more
2021Hepatology Research134 citations Open access
Semantic Scholar
Lusutrombopag Reduces Need for Platelet Transfusion in Patients With Thrombocytopenia Undergoing Invasive Procedures
H. Hidaka, M. Kurosaki, Hironori Tanaka, M. Kudo +16 more
2019Clinical Gastroenterology and Hepatology118 citations Open access
Semantic Scholar
Skeletal Muscle Mass Influences Tolerability and Prognosis in Hepatocellular Carcinoma Patients Treated with Lenvatinib
H. Uojima, M. Chuma, Yoshiaki Tanaka, H. Hidaka +10 more
2019Liver Cancer96 citations Open access
Semantic Scholar
Randomized, phase II trial of sequential hepatic arterial infusion chemotherapy and sorafenib versus sorafenib alone as initial therapy for advanced hepatocellular carcinoma: SCOOP-2 trial
M. Kondo, M. Morimoto, Satoshi Kobayashi, S. Ohkawa +13 more
2019BMC Cancer71 citations Open access
Semantic Scholar
S-1 versus placebo in patients with sorafenib-refractory advanced hepatocellular carcinoma (S-CUBE): a randomised, double-blind, multicentre, phase 3 trial.
M. Kudo, M. Moriguchi, K. Numata, H. Hidaka +12 more
2017The Lancet Gastroenterology and Hepatology53 citations
Semantic Scholar
Early Changes in Circulating FGF19 and Ang-2 Levels as Possible Predictive Biomarkers of Clinical Response to Lenvatinib Therapy in Hepatocellular Carcinoma
M. Chuma, H. Uojima, K. Numata, H. Hidaka +23 more
2020Cancers50 citations Open access
Semantic Scholar
Safety and Efﬁcacy of Lenvatinib Treatment in Child–Pugh A and B Patients with Unresectable Hepatocellular Carcinoma in Clinical Practice: A Multicenter Analysis
Katsuaki Ogushi, M. Chuma, H. Uojima, H. Hidaka +25 more
2020Clinical and Experimental Gastroenterology49 citations Open access
Semantic Scholar
Antithrombin III for portal vein thrombosis in patients with liver disease: A randomized, double‐blind, controlled trial
H. Hidaka, S. Kokubu, Takahiro Sato, S. Katsushima +10 more
2017Hepatology Research48 citations Open access
Semantic Scholar
Phase I/II study of first-line combination therapy with sorafenib plus resminostat, an oral HDAC inhibitor, versus sorafenib monotherapy for advanced hepatocellular carcinoma in east Asian patients
W. Tak, B. Ryoo, H. Lim, Do-Young Kim +19 more
2018Investigational new drugs47 citations
Semantic Scholar
Short-Term Safety and Efficacy of Balloon-Occluded Retrograde Transvenous Obliteration Using Ethanolamine Oleate: Results of a Prospective, Multicenter, Single-Arm Trial.
M. Kobayakawa, S. Kokubu, S. Hirota, J. Koizumi +6 more
2017Journal of Vascular and Interventional Radiology44 citations Open access
Semantic Scholar
Association Between Immune-Related Adverse Events and Survival in Patients with Hepatocellular Carcinoma Treated With Atezolizumab Plus Bevacizumab
Taito Fukushima, M. Morimoto, Satoshi Kobayashi, M. Ueno +13 more
2023The Oncologist40 citations Open access
Semantic Scholar
Safety and efficacy of atezolizumab plus bevacizumab in patients with unresectable hepatocellular carcinoma in early clinical practice: A multicenter analysis
M. Chuma, H. Uojima, N. Hattori, Yoshitaka Arase +23 more
2021Hepatology Research39 citations
Semantic Scholar
Effect of branched-chain amino acid supplements on muscle strength and muscle mass in patients with liver cirrhosis
H. Uojima, S. Sakurai, H. Hidaka, T. Kinbara +9 more
2017European Journal of Gastroenterology and Hepathology39 citations
Semantic Scholar
Modified response evaluation criteria in solid tumors is superior to response evaluation criteria in solid tumors for assessment of responses to sorafenib in patients with advanced hepatocellular carcinoma
Juichi Takada, H. Hidaka, T. Nakazawa, M. Kondo +8 more
2015BMC Research Notes38 citations Open access
Semantic Scholar
Analysis of efficacy of lenvatinib treatment in highly advanced hepatocellular carcinoma with tumor thrombus in the main trunk of the portal vein or tumor with more than 50% liver occupation: A multicenter analysis
M. Chuma, H. Uojima, A. Hiraoka, Satoshi Kobayashi +32 more
2020Hepatology Research34 citations
Semantic Scholar
Field practice study of half‐dose sorafenib treatment on safety and efficacy for hepatocellular carcinoma: A propensity score analysis
M. Morimoto, K. Numata, M. Kondo, Satoshi Kobayashi +10 more
2015Hepatology Research32 citations
Semantic Scholar
Portal hemodynamic effects of lenvatinib in patients with advanced hepatocellular carcinoma: A prospective cohort study
H. Hidaka, H. Uojima, T. Nakazawa, Xue-qing Shao +9 more
2020Hepatology Research31 citations
Semantic Scholar
Close correlation between urinary sodium excretion and response to tolvaptan in liver cirrhosis patients with ascites
H. Uojima, T. Kinbara, H. Hidaka, Hyun Sung Ji +8 more
2017Hepatology Research30 citations Open access
Semantic Scholar
Relationship between response to lusutrombopag and splenic volume
H. Uojima, Yoshitaka Arase, N. Itokawa, M. Atsukawa +10 more
2018World Journal of Gastroenterology23 citations Open access
Semantic Scholar
Hepatic arterial infusion chemotherapy with cisplatin and sorafenib in hepatocellular carcinoma patients unresponsive to transarterial chemoembolization: A propensity score‐based weighting
M. Kondo, M. Morimoto, T. Ishii, A. Nozaki +13 more
2015Journal of Digestive Diseases23 citations
Semantic Scholar
Quantitative measurements of M2BPGi depend on liver fibrosis and inflammation
H. Uojima, Kazumi Yamasaki, M. Sugiyama, Masayoshi Kage +24 more
2024Journal of gastroenterology22 citations
Semantic Scholar
Efficacy of combination therapy with natriuretic and aquaretic drugs in cirrhotic ascites patients: A randomized study
H. Uojima, H. Hidaka, T. Nakayama, Hyun Sung Ji +7 more
2017World Journal of Gastroenterology21 citations Open access
Semantic Scholar
Prospective study for an independent predictor of prognosis in liver cirrhosis based on the new sarcopenia criteria produced by the Japan Society of Hepatology
Nahoko Kikuchi, H. Uojima, H. Hidaka, S. Iwasaki +8 more
2021Hepatology Research18 citations
Semantic Scholar
Clinicopathological Features of Autoimmune Hepatitis with IgG4-Positive Plasma Cell Infiltration
Yoshitaka Arase, Koshi Matsumoto, Kazuya Anzai, Kota Tsuruya +12 more
2020Digestive Diseases17 citations Open access
Semantic Scholar
A case of immune checkpoint inhibitor-associated myocarditis after initiation of atezolizumab plus bevacizumab therapy for advanced hepatocellular carcinoma
S. Iwasaki, H. Hidaka, H. Uojima, Miho Hashimura +7 more
2021Clinical Journal of Gastroenterology15 citations
Semantic Scholar
Peliosis hepatis disseminated rapidly throughout the liver in a patient with prostate cancer: a case report
H. Hidaka, M. Ohbu, T. Nakazawa, Takaaki Matsumoto +2 more
2015Journal of Medical Case Reports15 citations Open access
Semantic Scholar
Usefulness of autotaxin for the complications of liver cirrhosis
Xue-qing Shao, H. Uojima, Toru Setsu, T. Okubo +11 more
2020World Journal of Gastroenterology14 citations Open access
Semantic Scholar
Subgroup analysis of efficacy and safety of orantinib in combination with TACE in Japanese HCC patients in a randomized phase III trial (ORIENTAL)
H. Hidaka, N. Izumi, T. Aramaki, M. Ikeda +15 more
2019Medical Oncology14 citations Open access
Semantic Scholar
A suspected case of Clostridium perfringens sepsis with intravascular hemolysis after transhepatic arterial chemoembolization: a case report
H. Uojima, M. Onoue, H. Hidaka, Naohisa Wada +6 more
2019Journal of Medical Case Reports14 citations Open access
Semantic Scholar
Clinical significance of circulating biomarkers of immune-checkpoint molecules with atezolizumab plus bevacizumab therapy in unresectable hepatocellular carcinoma
M. Chuma, H. Uojima, H. Toyoda, Atsushi Hiraoka +21 more
2024Hepatology International13 citations Open access
Semantic Scholar
A prospective observational cohort study of lenvatinib as initial treatment in patients with BCLC-defined stage B hepatocellular carcinoma
Satoshi Kobayashi, Taito Fukushima, M. Ueno, Satoshi Moriya +14 more
2022BMC Cancer13 citations Open access
Semantic Scholar
The Risk of Cirrhosis and Its Complications Based on PNPLA3 rs738409 G Allele Frequency
Xue-qing Shao, H. Uojima, T. Arai, Yuji Ogawa +14 more
2021Digestive Diseases13 citations Open access
Semantic Scholar
Risk factors for loss of skeletal muscle mass in patients with cirrhosis
Hyun Sung Ji, H. Uojima, H. Hidaka, Yoshiaki Tanaka +8 more
2019Hepatology Research12 citations
Semantic Scholar
Hepatic Congestion Leads to Fibrosis: Findings in a Newly Developed Murine Model
H. Hidaka, Y. Iwakiri
2015Hepatology12 citations Open access
Semantic Scholar
Evaluation of Skeletal Muscle Mass in Patients with Chronic Liver Disease Shows Different Results Based on Bioelectric Impedance Analysis and Computed Tomography
Nahoko Kikuchi, H. Uojima, H. Hidaka, S. Iwasaki +9 more
2022Annals of Nutrition and Metabolism10 citations Open access
Semantic Scholar
Impact of Anti-GPIIb/IIIa Antibody-Producing B Cells as a Predictor of the Response to Lusutrombopag in Thrombocytopenic Patients with Liver Disease
Naohisa Wada, H. Uojima, T. Satoh, S. Okina +14 more
2020Digestive Diseases10 citations Open access
Semantic Scholar
New chemiluminescent enzyme immunoassay for quantitative measurement of Mac-2 binding protein glycosylation isomer in chronic liver disease
H. Uojima, K. Nakabayashi, Kazumi Yamasaki, M. Sugiyama +28 more
2023Journal of gastroenterology9 citations
Semantic Scholar
Wisteria floribunda agglutinin‐positive human Mac‐2 binding protein in decompensated cirrhosis
H. Uojima, H. Hidaka, Yoshiaki Tanaka, Tomoyoshi Inoue +11 more
2018Journal of Gastroenterology and Hepatology9 citations
Semantic Scholar
A randomized, double-blind, placebo-controlled phase III study of S-1 in patients with sorafenib-refractory advanced hepatocellular carcinoma (S-CUBE).
M. Kudo, M. Moriguchi, K. Numata, H. Hidaka +6 more
20159 citations
Semantic Scholar
Clinical outcomes of antithrombin III‐based therapy for patients with portal vein thrombosis: A retrospective, multicenter study
K. Hayama, M. Atsukawa, A. Tsubota, Chisa Kondo +29 more
2022Hepatology Research8 citations
Semantic Scholar
Prospective, randomized, controlled study of the efficacy of transcatheter arterial chemoembolization with miriplatin for hepatocellular carcinoma
Kousuke Kubota, H. Hidaka, T. Nakazawa, Y. Okuwaki +11 more
2018Hepatology Research8 citations Open access
Semantic Scholar
Three‐dimensional computed tomography of portopulmonary venous anastomoses in patients with esophageal varices before treatment
Yasuhiro Matsumoto, H. Hidaka, Keiji Matsunaga, Kousuke Kubota +9 more
2016Hepatology Research8 citations
Semantic Scholar
A case of successful treatment with lenvatinib in primary hepatoid adenocarcinoma of the gallbladder that was difficult to distinguish from hepatocellular carcinoma
S. Iwasaki, H. Hidaka, H. Uojima, Hidefumi Kubo +6 more
2022Clinical Journal of Gastroenterology7 citations
Semantic Scholar
Comparative study between sorafenib and lenvatinib as the first‐line therapy in the sequential treatment of unresectable hepatocellular carcinoma in a real‐world setting
Taito Fukushima, M. Morimoto, M. Ueno, Kousuke Kubota +13 more
2021JGH Open7 citations Open access
Semantic Scholar
Influence of NOS3 rs2070744 genotypes on hepatocellular carcinoma patients treated with lenvatinib
Shintaro Azuma, H. Uojima, M. Chuma, Xue-qing Shao +9 more
2020Scientific Reports7 citations Open access
Semantic Scholar
Resminostat and sorafenib combination therapy for advanced hepatocellular carcinoma in patients previously untreated with systemic chemotherapy.
M. Kudo, B. Ryoo, H. Lim, D. Y. Kim +16 more
20177 citations
Semantic Scholar
Impact of body composition for patients with hepatocellular carcinoma who received atezolizumab plus bevacizumab therapy
H. Uojima, M. Chuma, H. Hidaka, T. Tsuda +14 more
2023European Journal of Gastroenterology and Hepathology6 citations
Semantic Scholar
Additional L-Carnitine Reduced the Risk of Hospitalization in Patients with Overt Hepatic Encephalopathy on Rifaximin
Kousuke Kubota, H. Uojima, Xue-qing Shao, S. Iwasaki +6 more
2021Digestive Diseases6 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

H. Uojima×32
Invite
H. Uojima — researcher profile on SciRah
T. Nakazawa×23
Invite
T. Nakazawa — researcher profile on SciRah
M. Kako×17
Invite
M. Kako — researcher profile on SciRah
W. Koizumi×17
Invite
W. Koizumi — researcher profile on SciRah

×16

Invite

T. Kagawa — researcher profile on SciRah

M. Morimoto×15

Invite

M. Morimoto — researcher profile on SciRah

Invite

K. Numata — researcher profile on SciRah

Naohisa Wada×14

Invite

Naohisa Wada — researcher profile on SciRah

Invite

A. Shibuya — researcher profile on SciRah

Invite

M. Chuma — researcher profile on SciRah

Kousuke Kubota×12

Invite

Kousuke Kubota — researcher profile on SciRah

Satoshi Kobayashi×11

Invite

Satoshi Kobayashi — researcher profile on SciRah